Stock Market Reviews

RNA (Avidity Biosciences, Inc.) News

Get the latest news, insights, and market updates on RNA (Avidity Biosciences, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Novartis’ $12B Avidity deal shows a willingness to take big swings in neuroscience
  A premium paid for RNA candidates reflects what the pharma giant has sought to do for the last few years: aim at revolutionary technology that fits into their own expertise.
  Oct 28, 2025 - $RNA
• S&P Futures Muted After Record Rally, FOMC Meeting and Earnings in Focus
  December S&P 500 E-Mini futures (ESZ25) are trending down -0.02% this morning, taking a breather after a record-breaking rally, while investors await the start of the Federal Reserve’s two-day policy meeting, a new round of corporate earnings reports, and U.S. private-sector economic data.
  Oct 28, 2025 - $RNA
• Why Dyne Therapeutics Stock Crushed the Market on Monday
  Biotechs like it are clearly valuable to strategic acquirers.
  Oct 27, 2025 - $RNA
• Why Avidity Biosciences Stock Blasted 42% Higher Today
  If all goes well, the company will be part of a much larger enterprise starting next year.
  Oct 27, 2025 - $RNA
• Stocks to Watch Monday: Amazon, Nvidia, Novartis, Keurig Dr Pepper
  ↗️ AMD (AMD), ARM Holdings (ARM): Chip stocks and shares in other big technology companies rallied after upbeat comments from both U.S. and China following weekend trade talks. ↗️Amazon.com (AMZN): The tech giant, whose shares rose 1.
  Oct 27, 2025 - $RNA
• Health Care Roundup: Market Talk
  Find insight on Novartis, Lonza and more in the latest Market Talks covering the health care sector.
  Oct 27, 2025 - $RNA